All In MedTech

Device type · JLW

Radioimmunoassay, Thyroid-Stimulating Hormone

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about JLW: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

JLW

Clinical Chemistry

Device class

Class II

FDA decisions since 2015

17

510(k), De Novo and PMA

Adverse event reports

123

Received Nov 1, 2025 to Nov 19, 2026

How FDA classifies it

Device type
Radioimmunoassay, Thyroid-Stimulating Hormone
Product code
JLW
Device class
Class II
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1690

Latest FDA decisions

The 8 newest of 17 since 2015.

All decisions for JLW

14 more FDA decisions with a free account

Reports received

123

Received Nov 1, 2025 to Nov 19, 2026. Includes 9 of another or unstated type.

Malfunction reports

111

90% of reports

Injury reports

3

2.4% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 2313000
Jan 2411000
Feb 2420000
Mar 2417000
Apr 2427000
May 2412000
Jun 2410100
Jul 2417100
Aug 244100
Sep 2418100
Oct 2411000
Nov 247000
Dec 2411000
Jan 258000
Feb 258000
Mar 2517000
Apr 2517000
May 2510000
Jun 259000
Jul 256000
Aug 252000
Sep 258000
Oct 258000
Nov 256000
Dec 255000
Jan 2619100
Feb 265000
Mar 269000
Apr 2613100
May 261000
Jun 265000
Jul 262005
Aug 263000
Sep 2613100
Oct 2630004
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

4 more in this ranking with a free account

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • Low Test Results60
  • High Test Results48
  • Imprecise or Erratic Results7

7 more in this ranking with a free account

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • No Clinical Signs, Symptoms or Conditions115
  • Insufficient Information7
  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Thyroid TSH TestOpen, Classified

    GET TESTED INTERNATIONAL AB

    Z-0752-2026 · Started Nov 3, 2025 · Posted by FDA Dec 1, 2025

    Reason given: Distribution without premarket approval/clearance.

    Cause as FDA categorized it: No Marketing Application

  • Beckman Coulter, Inc.

    Z-0216-2026 · Started Sep 19, 2025 · Posted by FDA Oct 21, 2025

    Reason given: Beckman Coulter has confirmed a software anomaly on DxI 9000 Access Immunoassay Analyzer and the DxC 500i Clinical Analyzer that may prevent correct application of user-specified manual dilution factors when ordering additional tests for samples already "In Progress" using the same "Sample ID number". This can lead to...

    Cause as FDA categorized it: Software design

  • Beckman Coulter, Inc.

    Z-1913-2025 · Started Apr 23, 2025 · Posted by FDA Jun 5, 2025

    Reason given: A new software update (v1.20) is introducing error codes for the Dxl 9000 which prevents the assay from being performed and a delay in results from being generated, and may require field service to resolve the delay.

    Cause as FDA categorized it: Software design

43 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.